Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Melatonin and human cancer.
Dogliotti L, Berruti A, Buniva T, Torta M, Bottini A, Tampellini M, Terzolo M, Faggiuolo R, Angeli A. Dogliotti L, et al. Among authors: buniva t. J Steroid Biochem Mol Biol. 1990 Dec 20;37(6):983-7. doi: 10.1016/0960-0760(90)90454-s. J Steroid Biochem Mol Biol. 1990. PMID: 2285610
Relationship between CA 15-3 serum levels and disease extent in predicting overall survival of breast cancer patients with newly diagnosed metastatic disease.
Tampellini M, Berruti A, Gerbino A, Buniva T, Torta M, Gorzegno G, Faggiuolo R, Cannone R, Farris A, Destefanis M, Moro G, Deltetto F, Dogliotti L. Tampellini M, et al. Among authors: buniva t. Br J Cancer. 1997;75(5):698-702. doi: 10.1038/bjc.1997.124. Br J Cancer. 1997. PMID: 9043027 Free PMC article.
Prognostic factors in metastatic breast cancer patients obtaining objective response or disease stabilization after first-line chemotherapy with epirubicin. Evidence for a positive effect of maintenance hormonal therapy on overall survival.
Berruti A, Zola P, Buniva T, Baù MG, Farris A, Sarobba MG, Bottini A, Tampellini M, Durando A, Destefanis M, Monzeglio C, Moro G, Sussio M, Perroni D, Dogliotti L. Berruti A, et al. Among authors: buniva t. Anticancer Res. 1997 Jul-Aug;17(4A):2763-8. Anticancer Res. 1997. PMID: 9252712 Clinical Trial.
Randomized comparison of goserelin acetate versus mitomycin C plus goserelin acetate in previously untreated prostate cancer patients with bone metastases.
Fontana D, Bertetto O, Fasolis G, Berruti A, Tarabuzzi R, Pagani G, Buniva T, Zolfanelli R, Pallotti S, Frezzotti L, Bumma C, Rossetti SR, Dogliotti L. Fontana D, et al. Among authors: buniva t. Tumori. 1998 Jan-Feb;84(1):39-44. doi: 10.1177/030089169808400108. Tumori. 1998. PMID: 9619712 Clinical Trial.
Lonidamine significantly increases the activity of epirubicin in patients with advanced breast cancer: results from a multicenter prospective randomized trial.
Dogliotti L, Berruti A, Buniva T, Zola P, Baù MG, Farris A, Sarobba MG, Bottini A, Alquati P, Deltetto F, Gosso P, Monzeglio C, Moro G, Sussio M, Perroni D. Dogliotti L, et al. Among authors: buniva t. J Clin Oncol. 1996 Apr;14(4):1165-72. doi: 10.1200/JCO.1996.14.4.1165. J Clin Oncol. 1996. PMID: 8648371 Clinical Trial.